|
POM121 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16599999988587E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.980400E-04 |
| Normal-vs-Stage2 |
3.036300E-02 |
| Normal-vs-Stage3 |
1.521030E-01 |
| Normal-vs-Stage4 |
1.042810E-01 |
| Stage1-vs-Stage2 |
5.726800E-01 |
| Stage1-vs-Stage3 |
4.617000E-01 |
| Stage1-vs-Stage4 |
9.963600E-01 |
| Stage2-vs-Stage3 |
2.686800E-01 |
| Stage2-vs-Stage4 |
6.873000E-01 |
| Stage3-vs-Stage4 |
5.931800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.39760000034728E-07 |
| Normal-vs-AfricanAmerican |
1.346410E-02 |
| Normal-vs-Asian |
9.528200E-01 |
| Caucasian-vs-AfricanAmerican |
3.531200E-01 |
| Caucasian-vs-Asian |
3.248200E-02 |
| AfricanAmerican-vs-Asian |
4.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.96909999995133E-07 |
| Normal-vs-Female |
4.755200E-04 |
| Male-vs-Female |
8.181800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.446500E-02 |
| Normal-vs-Extreme_Weight |
1.031550E-02 |
| Normal-vs-Obese |
3.969200E-04 |
| Normal-vs-Extreme_Obese |
1.429350E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.926800E-01 |
| Normal_Weight-vs-Obese |
4.850400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.498200E-01 |
| Extreme_Weight-vs-Obese |
5.478800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.257000E-01 |
| Obese-vs-Extreme_Obese |
9.236200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.308060E-02 |
| Normal-vs-Age(41-60Yrs) |
1.32310000000579E-06 |
| Normal-vs-Age(61-80Yrs) |
4.826700E-04 |
| Normal-vs-Age(81-100Yrs) |
7.998800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.670400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.491000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.621650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.777600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.305560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.264800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.74279981744053E-10 |
| Normal-VS-Type2 PRCC |
3.649800E-01 |
| Normal-VS-KIRP CIMP |
3.665400E-01 |
| Normal-VS-Unclassified PRCC |
1.278360E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.25570000000186E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.760410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.927000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.761800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.291800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.927200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.385810E-01 |
| Normal-vs-N1 |
6.942300E-02 |
| Normal-vs-N2 |
2.929400E-01 |
| N0-vs-N1 |
6.975800E-01 |
| N0-vs-N2 |
9.636200E-01 |
| N1-vs-N2 |
7.781400E-01 |
|
|
